Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C KINNEY

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|January 23, 2024
Orthotopic injection of an established syngeneic mouse oral cancer cell line (MOC1) induces a robust draining lymph node responseVikash Kansal, Brendan L C Kinney, Nicole C Schmitt
Head & Neck|March 6, 2024
Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosaVikash Kansal, Brendan L C Kinney, Nicole C Schmitt
Head & Neck|October 17, 2025
A Practical Method for Detecting Prognostic CD57+ T Cells in Head and Neck CancerBrianna Brammer, Brendan L C Kinney, Vikash Kansal, et al.
Cancer Medicine|May 3, 2023
The expanding role of IAP antagonists for the treatment of head and neck cancerVikash Kansal, Brendan L C Kinney, Srijayaprakash Uppada, et al.
Journal for Immunotherapy of Cancer|January 17, 2023
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer modelsVikash Kansal, Andre J Burnham, Brendan L C Kinney, et al.
OTO Open|September 29, 2025
Does Water Irrigation Control Pleomorphic Adenoma Cell Growth Better Than Saline?Nathaniel Neptune, Anuhya Kanchibhatla, Kelly R Magliocca, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53Brendan L C Kinney, Sreenivasulu Gunti, Vikash Kansal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2025
Early-phase trial of IAP antagonist tolinapant and definitive radiation in cisplatin-ineligible patients with advanced head and neck cancerNicole C Schmitt, William A Stokes, James E Bates, et al.
Oncoimmunology|June 18, 2024
CD28-CD57+ T cells from head and neck cancer patients produce high levels of cytotoxic granules and type II interferon but are not senescentBrendan L C Kinney, Brianna Brammer, Vikash Kansal, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|January 23, 2024
Orthotopic injection of an established syngeneic mouse oral cancer cell line (MOC1) induces a robust draining lymph node responseVikash Kansal, Brendan L C Kinney, Nicole C Schmitt
Head & Neck|March 6, 2024
Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosaVikash Kansal, Brendan L C Kinney, Nicole C Schmitt
Head & Neck|October 17, 2025
A Practical Method for Detecting Prognostic CD57+ T Cells in Head and Neck CancerBrianna Brammer, Brendan L C Kinney, Vikash Kansal, et al.
Cancer Medicine|May 3, 2023
The expanding role of IAP antagonists for the treatment of head and neck cancerVikash Kansal, Brendan L C Kinney, Srijayaprakash Uppada, et al.
Journal for Immunotherapy of Cancer|January 17, 2023
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer modelsVikash Kansal, Andre J Burnham, Brendan L C Kinney, et al.
OTO Open|September 29, 2025
Does Water Irrigation Control Pleomorphic Adenoma Cell Growth Better Than Saline?Nathaniel Neptune, Anuhya Kanchibhatla, Kelly R Magliocca, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53Brendan L C Kinney, Sreenivasulu Gunti, Vikash Kansal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2025
Early-phase trial of IAP antagonist tolinapant and definitive radiation in cisplatin-ineligible patients with advanced head and neck cancerNicole C Schmitt, William A Stokes, James E Bates, et al.
Oncoimmunology|June 18, 2024
CD28-CD57+ T cells from head and neck cancer patients produce high levels of cytotoxic granules and type II interferon but are not senescentBrendan L C Kinney, Brianna Brammer, Vikash Kansal, et al.
Pageof 1